Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTAW) Revenue (2020 - 2025)

Historic Revenue for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to $49.3 million.

  • Strata Critical Medical's Revenue rose 3670.35% to $49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $312.7 million, marking a year-over-year increase of 5402.49%. This contributed to the annual value of $248.7 million for FY2024, which is 1044.19% up from last year.
  • Latest data reveals that Strata Critical Medical reported Revenue of $49.3 million as of Q3 2025, which was up 3670.35% from $70.8 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year Revenue high stood at $138.3 million for Q4 2024, and its period low was $9.3 million during Q1 2021.
  • Its 5-year average for Revenue is $47.7 million, with a median of $45.7 million in 2022.
  • As far as peak fluctuations go, Strata Critical Medical's Revenue surged by 27670.16% in 2021, and later crashed by 4952.27% in 2024.
  • Quarter analysis of 5 years shows Strata Critical Medical's Revenue stood at $24.6 million in 2021, then skyrocketed by 54.91% to $38.1 million in 2022, then increased by 24.5% to $47.5 million in 2023, then soared by 191.22% to $138.3 million in 2024, then tumbled by 64.35% to $49.3 million in 2025.
  • Its Revenue stands at $49.3 million for Q3 2025, versus $70.8 million for Q2 2025 and $54.3 million for Q1 2025.